In the BioHarmony Drug Report Database
Diethylstilbestrol, Stilbestrol, Stilbetin (diethylstilbestrol) is a small molecule pharmaceutical. Diethylstilbestrol was first approved as Diethylstilbestrol on 1982-01-01. It is used to treat breast neoplasms, carcinoma, and prostatic neoplasms in the USA. The pharmaceutical is active against estrogen receptor. In addition, it is known to target steroid hormone receptor ERR1, estrogen-related receptor gamma, estrogen receptor beta, and steroid hormone receptor ERR2.
Image (chem structure or protein)